Pathstone Holdings
GMED icon

Pathstone Holdings’s Globus Medical GMED Stock Holding History

Pathstone Holdings’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.94M Sell
49,859
-4,811
-9% -$409K 0.01% 758
2026
Q1 		$4.71M Buy
54,670
+1,873
+4% +$168K 0.02% 587
2025
Q4 		$4.61M Buy
52,797
+1,554
+3% +$118K 0.02% 596
2025
Q3 		$2.93M Buy
51,243
+16,567
+48% +$954K 0.01% 822
2025
Q2 		$2.05M Sell
34,676
-9,616
-22% -$621K 0.01% 978
2025
Q1 		$3.24M Buy
44,292
+2,032
+5% +$168K 0.01% 734
2024
Q4 		$3.5M Buy
42,260
+1,253
+3% +$98.8K 0.02% 690
2024
Q3 		$2.93M Buy
41,007
+1,055
+3% +$74.5K 0.01% 779
2024
Q2 		$2.74M Buy
39,952
+5,919
+17% +$354K 0.01% 776
2024
Q1 		$1.83M Buy
34,033
+13,440
+65% +$723K 0.01% 948
2023
Q4 		$1.1M Buy
+20,593
New +$1M 0.01% 1035

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Pathstone Holdings's GMED Position: Q2 2026 in Review

Pathstone Holdings reduced its Globus Medical (GMED) stake by 8.8% in Q2 2026, selling an estimated $409K and leaving 49,859 shares worth $3.94M. The position accounts for 0.01% of the portfolio, ranked #758.

Pathstone Holdings first reported a position in GMED in Q4 2023 and has held it in 11 quarters since. The position peaked at $4.71M in Q1 2026. 596 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Pathstone Holdings held 49,859 shares of Globus Medical worth $3.94M as of Q2 2026.
  • Pathstone Holdings sold 4,811 Globus Medical shares in Q2 2026, an estimated $409K.
  • Globus Medical made up 0.01% of Pathstone Holdings's portfolio in Q2 2026, its #758 holding.
  • Pathstone Holdings first reported a position in Globus Medical in Q4 2023 and has held it in 11 quarters since.
  • Pathstone Holdings's Globus Medical position peaked at $4.71M in Q1 2026.
  • 596 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.